Delivering Biopsychosocial Health Care Within Routine Care: Spotlight-AQ Pivotal Multicenter Randomized Controlled Trial Results.

IF 4.1 Q2 ENDOCRINOLOGY & METABOLISM
Ryan Charles Kelly, Hermione Price, Peter Phiri, Michael Cummings, Amar Ali, Mayank Patel, Ethan Barnard, Yufan Liu, Oscar Mendez, Katharine Barnard-Kelly
{"title":"Delivering Biopsychosocial Health Care Within Routine Care: Spotlight-AQ Pivotal Multicenter Randomized Controlled Trial Results.","authors":"Ryan Charles Kelly, Hermione Price, Peter Phiri, Michael Cummings, Amar Ali, Mayank Patel, Ethan Barnard, Yufan Liu, Oscar Mendez, Katharine Barnard-Kelly","doi":"10.1177/19322968231183436","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Annual national diabetes audit data consistently shows most people with diabetes do not consistently achieve blood glucose targets for optimal health, despite the large range of treatment options available.</p><p><strong>Aim: </strong>To explore the efficacy of a novel clinical intervention to address physical and mental health needs within routine diabetes consultations across health care settings.</p><p><strong>Methods: </strong>A multicenter, parallel group, individually randomized trial comparing consultation duration in adults diagnosed with T1D or T2D for ≥6 months using the Spotlight-AQ platform versus usual care. Secondary outcomes were HbA1c, depression, diabetes distress, anxiety, functional health status, and healthcare professional burnout. Machine learning models were utilized to analyze the data collected from the Spotlight-AQ platform to validate the reliability of question-concern association; as well as to identify key features that distinguish people with type 1 and type 2 diabetes, as well as important features that distinguish different levels of HbA1c.</p><p><strong>Results: </strong><i>n</i> = 98 adults with T1D or T2D; any HbA1c and receiving any diabetes treatment participated (<i>n =</i> 49 intervention). Consultation duration for intervention participants was reduced in intervention consultations by 0.5 to 4.1 minutes (3%-14%) versus no change in the control group (-0.9 to +1.28 minutes). HbA1c improved in the intervention group by 6 mmol/mol (range 0-30) versus control group 3 mmol/mol (range 0-8). Moderate improvements in psychosocial outcomes were seen in the intervention group for functional health status; reduced anxiety, depression, and diabetes distress and improved well-being. None were statistically significant. HCPs reported improved communication and greater focus on patient priorities in consultations. Artificial Intelligence examination highlighted therapy and psychological burden were most important in predicting HbA1c levels. The Natural Language Processing semantic analysis confirmed the mapping relationship between questions and their corresponding concerns. Machine learning model revealed type 1 and type 2 patients have different concerns regarding psychological burden and knowledge. Moreover, the machine learning model emphasized that individuals with varying levels of HbA1c exhibit diverse levels of psychological burden and therapy-related concerns.</p><p><strong>Conclusion: </strong>Spotlight-AQ was associated with shorter, more useful consultations; with improved HbA1c and moderate benefits on psychosocial outcomes. Results reflect the importance of a biopsychosocial approach to routine care visits. Spotlight-AQ is viable across health care settings for improved outcomes.</p>","PeriodicalId":15475,"journal":{"name":"Journal of Diabetes Science and Technology","volume":" ","pages":"91-97"},"PeriodicalIF":4.1000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688703/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19322968231183436","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Annual national diabetes audit data consistently shows most people with diabetes do not consistently achieve blood glucose targets for optimal health, despite the large range of treatment options available.

Aim: To explore the efficacy of a novel clinical intervention to address physical and mental health needs within routine diabetes consultations across health care settings.

Methods: A multicenter, parallel group, individually randomized trial comparing consultation duration in adults diagnosed with T1D or T2D for ≥6 months using the Spotlight-AQ platform versus usual care. Secondary outcomes were HbA1c, depression, diabetes distress, anxiety, functional health status, and healthcare professional burnout. Machine learning models were utilized to analyze the data collected from the Spotlight-AQ platform to validate the reliability of question-concern association; as well as to identify key features that distinguish people with type 1 and type 2 diabetes, as well as important features that distinguish different levels of HbA1c.

Results: n = 98 adults with T1D or T2D; any HbA1c and receiving any diabetes treatment participated (n = 49 intervention). Consultation duration for intervention participants was reduced in intervention consultations by 0.5 to 4.1 minutes (3%-14%) versus no change in the control group (-0.9 to +1.28 minutes). HbA1c improved in the intervention group by 6 mmol/mol (range 0-30) versus control group 3 mmol/mol (range 0-8). Moderate improvements in psychosocial outcomes were seen in the intervention group for functional health status; reduced anxiety, depression, and diabetes distress and improved well-being. None were statistically significant. HCPs reported improved communication and greater focus on patient priorities in consultations. Artificial Intelligence examination highlighted therapy and psychological burden were most important in predicting HbA1c levels. The Natural Language Processing semantic analysis confirmed the mapping relationship between questions and their corresponding concerns. Machine learning model revealed type 1 and type 2 patients have different concerns regarding psychological burden and knowledge. Moreover, the machine learning model emphasized that individuals with varying levels of HbA1c exhibit diverse levels of psychological burden and therapy-related concerns.

Conclusion: Spotlight-AQ was associated with shorter, more useful consultations; with improved HbA1c and moderate benefits on psychosocial outcomes. Results reflect the importance of a biopsychosocial approach to routine care visits. Spotlight-AQ is viable across health care settings for improved outcomes.

在常规护理中提供生物心理社会健康护理:Spotlight-AQ关键性多中心随机对照试验结果。
背景:全国糖尿病年度审计数据一致显示,尽管有多种治疗方案可供选择,但大多数糖尿病患者并不能持续达到血糖目标,从而获得最佳健康状况。目的:探讨一种新型临床干预措施的疗效,以满足不同医疗机构常规糖尿病咨询中的身心健康需求:多中心、平行组、单独随机试验,比较使用 Spotlight-AQ 平台与常规护理对确诊为 T1D 或 T2D 的成人进行咨询的持续时间。次要结果为 HbA1c、抑郁、糖尿病困扰、焦虑、功能性健康状况和医护人员职业倦怠。利用机器学习模型分析从Spotlight-AQ平台收集的数据,以验证问题与关注点关联的可靠性,并确定区分1型和2型糖尿病患者的关键特征,以及区分不同HbA1c水平的重要特征。干预组参与者的咨询时间缩短了 0.5 到 4.1 分钟(3%-14%),而对照组没有变化(-0.9 到 +1.28 分钟)。干预组的 HbA1c 改善了 6 mmol/mol(范围 0-30),对照组改善了 3 mmol/mol(范围 0-8)。干预组在社会心理方面的结果有适度改善,包括功能性健康状况、焦虑、抑郁和糖尿病困扰减少以及幸福感提高。这些改善均无统计学意义。高级保健人员报告说,他们在咨询中改善了沟通,更加关注病人的优先事项。人工智能检查强调治疗和心理负担对预测 HbA1c 水平最为重要。自然语言处理语义分析证实了问题与相应关注点之间的映射关系。机器学习模型显示,1 型和 2 型患者在心理负担和知识方面有不同的关注点。此外,机器学习模型还强调,不同HbA1c水平的个体会表现出不同程度的心理负担和治疗相关问题:结论:Spotlight-AQ 可缩短咨询时间,提高咨询效率;改善 HbA1c,并对心理社会结果有一定的益处。研究结果反映了生物心理社会学方法在常规护理就诊中的重要性。Spotlight-AQ适用于各种医疗机构,可改善治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Diabetes Science and Technology
Journal of Diabetes Science and Technology Medicine-Internal Medicine
CiteScore
7.50
自引率
12.00%
发文量
148
期刊介绍: The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信